Welcome! The Huntington Study Group (HSG) is a non-profit group of clinical investigators from medical centers in the United States, Canada, Europe, Australia and New Zealand,  experienced in the care of patients and families affected by Huntington disease and dedicated to clinical research of this hereditary disorder. The HSG focuses on the conception, conduct and communication of clinical research, including treatment trials and observational studies aimed at relieving the burden and slowing the progression of Huntington disease. Please see Clinical Trials and Observational Studies in Progress for the current HSG trials.

 


UPCOMING TRIALS
December 2009 - PREQUEL will soon be enrolling. Please check back for updates on this and other potential future trials.

ENROLLING TRIALS AND STUDIES
December 2009 - The treatment trials that are currently enrolling 2CARE, CREST-E, HART and HORIZON.
December 2009 - The observational studies that are currently enrolling are COHORT and PREDICT-HD.
Please see Clinical Trials and Observational Studies in Progress for a list of all ongoing HSG trials.

HUNTINGTON SOCIETY OF CANADA/HSG RESEARCH GRANT
Required Letter of Intent due February 1, 2010 
Please see Request for Proposals for more information.
  
A Closer Look...

The Huntington Study Group is expanding! We have added 8 new HSG Research Sites. Please see the August 18, 2009 News Page entry for more information.

This is an exciting and busy time for HD researchers and the community. The Huntington Study Group has 7 studies that are either enrolling, or soon to be enrolling participants. Please see the HSG Study Flyer (June 2009) for a detailed chart view of these enrolling studies and clinical trials. Feel free to print the information and discuss it with your family, friends and medical professionals.